Phoenix, Arizona
Colorectal cancer clinical trials in Phoenix, AZ
28 colorectal cancer studies are recruiting participants at sites in Phoenix as of November 16, 2026, according to ClinicalTrials.gov. Colorectal Cancer Clinical Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Phoenix at a glance
- 28 studies are recruiting at a site in Phoenix.
- By phase: Phase 1 (8), Phase 1/2 (4), Phase 2 (3), Phase 2/3 (1), Phase 3 (5), No phase (3), Observational (4). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (16), university, hospital or other (11), government (1).
- Most recent update to one of these records: November 16, 2026.
Studies recruiting in Phoenix
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Study site
- Banner-University Medical Center Phoenix
- Registry record
- NCT05863195 · updated
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Mayo Clinic - Arizona ( Site 0090)
- Registry record
- NCT06997497 · updated
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- SWOG Cancer Research Network
- Study site
- Cancer Center at Saint Joseph's
- Registry record
- NCT07018869 · updated
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- No phase
- Ages 45 to 70
- All sexes
- Sponsor
- NRG Oncology
- Study site
- Cancer Center at Saint Joseph's
- Registry record
- NCT05080673 · updated
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- Phase 2/3
- Ages 18 and older
- All sexes
- Sponsor
- NRG Oncology
- Study site
- Cancer Center at Saint Joseph's
- Registry record
- NCT05174169 · updated
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Observational
- Ages 40 to 75
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study site
- Cancer Center at Saint Joseph's
- Registry record
- NCT05334069 · updated
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Wake Forest University Health Sciences
- Study site
- Cancer Center at Saint Joseph's
- Registry record
- NCT06418204 · updated
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study site
- Cancer Center at Saint Joseph's
- Registry record
- NCT07283939 · updated
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study site
- Mayo Clinic Hospital in Arizona
- Registry record
- NCT05673148 · updated
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Kumquat Biosciences Inc.
- Study site
- Mayo Clinic, Phoenix
- Registry record
- NCT06720987 · updated
Family Communications After Genetic Testing
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study site
- Cancer Center at Saint Joseph's
- Registry record
- NCT07143487 · updated
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- A2 Biotherapeutics Inc.
- Study site
- Mayo Clinic Hospital
- Registry record
- NCT04981119 · updated
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Kura Oncology, Inc.
- Study site
- Mayo Clinic Comprehensive Cancer Center
- Registry record
- NCT06026410 · updated
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Pfizer
- Study sites
- Ironwood Cancer & Research Centers · Mayo Clinic Building- Phoenix · Mayo Clinic Hospital
- Registry record
- NCT07222800 · updated
FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Parabilis Medicines, Inc.
- Study site
- Mayo Clinic
- Registry record
- NCT05919264 · updated
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Exelixis
- Study site
- Exelixis Clinical Site #67
- Registry record
- NCT05176483 · updated
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- Mayo Clinic Hospital
- Registry record
- NCT06445062 · updated
An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- Mayo Clinic Hospital in Arizona
- Registry record
- NCT06557733 · updated
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Cartography Biosciences
- Study site
- Mayo Clinic Arizona
- Registry record
- NCT07321106 · updated
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Xencor, Inc.
- Study site
- Xencor Investigative Site
- Registry record
- NCT05433142 · updated
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- MOMA Therapeutics
- Registry record
- NCT06974110 · updated
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Seagen, a wholly owned subsidiary of Pfizer
- Study site
- Mayo Clinic Hospital
- Registry record
- NCT06131840 · updated
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Incyte Corporation
- Study site
- Mayo Clinic Hospital
- Registry record
- NCT06179160 · updated
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Ono Pharmaceutical Co., Ltd.
- Study site
- Mayo Clinic Arizona
- Registry record
- NCT06948448 · updated
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Canadian Cancer Trials Group
- Study site
- Cancer Center at Saint Joseph's
- Registry record
- NCT06205485 · updated
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Alentis Therapeutics AG
- Study site
- Mayo Clinic Comprehensive Cancer Center
- Registry record
- NCT07169734 · updated
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- 858 Therapeutics, Inc.
- Study site
- Mayo Clinic
- Registry record
- NCT06395519 · updated
Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Mayo Clinic
- Study site
- Mayo Clinic in Arizona
- Registry record
- NCT06349642 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Phoenix, AZ on ClinicalTrials.gov.
Ask about studies near Phoenix
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections